Neurosyphilis laboratory findings

Revision as of 18:11, 18 September 2017 by WikiBot (talk | contribs) (Changes made per Mahshid's request)
Jump to navigation Jump to search


Neurosyphilis Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Neurosyphilis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neurosyphilis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurosyphilis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurosyphilis laboratory findings

CDC on Neurosyphilis laboratory findings

Neurosyphilis laboratory findings in the news

Blogs on Neurosyphilis laboratory findings

Directions to Hospitals Treating Neurosyphilis

Risk calculators and risk factors for Neurosyphilis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Approximately 35% to 40% of persons with secondary syphilis have asymptomatic central nervous system (CNS) involvement, as demonstrated by an abnormal leukocyte cell count, protein level, or glucose level or a demonstrated reactivity to Venereal Disease Research Laboratory (VDRL) antibody test on cerebrospinal fluid (CSF) examination. Laboratory testing is helpful in supporting the diagnosis of neurosyphilis; however, no single test can be used to diagnose neurosyphilis in all instances.

Laboratory Findings

CSF Analysis

  • Diagnosed by finding high numbers of leukocytes in the CSF or abnormally high protein concentration in the setting of syphilis infection.
  • VDRL in cerebrospinal fluid (CSF-VDRL), which is highly specific but insensitive, is the standard serologic test for CSF. Although some advocate using the FTA-ABS test to improve sensitivity.
  • When reactive in the absence of substantial contamination of CSF with blood, it is considered diagnostic of neurosyphilis; however in early syphilis, it can be of unknown prognostic significance.[1]
  • Most other tests are both insensitive and nonspecific and must be interpreted in relation to other test results and the clinical assessment. Therefore, the laboratory diagnosis of neurosyphilis usually depends on various combinations of reactive serologic test results, CSF cell count or protein, and a reactive CSF-VDRL with or without clinical manifestations.

HIV Co-infection

  • There is anecdotal evidence that the incidence of neurosyphilis is higher in HIV patients, and some have recommended that all HIV-positive patients with syphilis should have a lumbar puncture to look for asymptomatic neurosyphilis.[2]
  • Among persons with HIV infection, the CSF leukocyte count usually is elevated (>5 white blood cell count [WBC]/mm3); using a higher cutoff (>20 WBC/ mm3) might improve the specificity of neurosyphilis diagnosis.[3]
  • The CSF-VDRL might be non-reactive even when neurosyphilis is present.

References

  1. Lukehart SA, Hook EW, Baker-Zander SA, Collier AC, Critchlow CW, Handsfield HH (1988). "Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment". Annals of Internal Medicine. 109 (11): 855–62. PMID 3056164. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  2. Walter T, Lebouche B, Miailhes P; et al. (2006). "Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients". Clin Infect Dis. 43 (6): 787–90. PMID 16912958.
  3. Marra CM, Maxwell CL, Smith SL, Lukehart SA, Rompalo AM, Eaton M, Stoner BP, Augenbraun M, Barker DE, Corbett JJ, Zajackowski M, Raines C, Nerad J, Kee R, Barnett SH (2004). "Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features". The Journal of Infectious Diseases. 189 (3): 369–76. doi:10.1086/381227. PMID 14745693. Retrieved 2012-02-16. Unknown parameter |month= ignored (help)
  4. Jaffe HW, Larsen SA, Peters M, Jove DF, Lopez B, Schroeter AL (1978). "Tests for treponemal antibody in CSF". Archives of Internal Medicine. 138 (2): 252–5. PMID 343742. Retrieved 2012-02-16. Unknown parameter |month= ignored (help)

Template:WH Template:WS